Tesamorelin (Egrifta, Egrifta SV) is FDA-approved for the treatment of HIV-associated lipodystrophy (excess abdominal fat in HIV-positive patients on antiretroviral therapy)
Our formulations are evaluated for real-world performance, ensuring that they deliver results as promised
Slower titration when needed reduces the dropout rate from intolerable symptoms
Are you struggling with managing your Type 2 diabetes
Embarking on a Zepbound weight loss journey reveals many beneficial changes: Reduced cravings, particularly for high-calorie foods, leading to more manageable appetite
Additionally, ensure you stay adequately hydrated, as dehydration can sometimes influence heart rate, and actively manage stress through relaxation techniques, given its potential impact on heart rate and palpitations